2025 · 2nd Quarter (Apr 1 - June 30)

BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)

Filed by BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.).

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: Not reported
Expenses: $220,000.00
Registrant: BEONE MEDICINES USA, INC. (FORMERLY BEIGENE USA, INC.)
Client: BEONE MEDICINES USA, INC (FORMERLY BEIGENE USA, INC.)
Filing UUID: b8660dbe-90f0-47e4-9d18-c0a3bad0c919
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to drug pricing; Issues related to the drug approval and review process; issues related to operations of the Department of Veterans Affairs including work with clinical trials and research studies; implementation of the Inflation Reduction Act; ORPHAN Cures Act and pharmacy benefit manager legislation; ORPHAN Cures Act language in H.R. 1, One Big Beautiful Bill Act

Literal federal measure citations: H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.